COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS and Complete, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

MetLite™ by Cleveland Diabetes Care

Metformin is the most-prescribed medication for the treatment of diabetes, but over a third of patients report unpleasant gastrointestinal side effects from the drug and have difficulty swallowing the cumbersome pills.

Many patients end up discontinuing their metformin prescriptions.

MetLite™ by Cleveland Diabetes Care is a pleasant-tasting, effervescent formulation of metformin that dissolves in water. Made with potassium (instead of sodium commonly found in other metformin drugs), MetLite™ has been found to cause significantly less gastrointestinal side effects in patients while delivering the same therapeutic results.

Easy to take. No unpleasant taste. Improved patient compliance.

Key project advantages

  • Rapid path to market 505b(2) – 2019 approval projected;
  • Anticipated market exclusivity through 2034;
  • Technology already produced by EffRx;
  • Clinical partners available 2019;
  • Patented, sodium-free, potassium-based formulation;
  • Optimal taste-masking formulation.